Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 3 10Phase 4 5Phase 2/3 3Phase 1 3Phase NA 2Phase 1/2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

Radiosurgery 73Magnetic Resonance Spectroscopy 48Standard of Care 41Radiotherapy 36Exercise 36Blood Specimen Collection 28Early Intervention, Educational 26Surveys and Questionnaires 24Multiparametric Magnetic Resonance Imaging 22Magnetic Resonance Imaging 21Brachytherapy 21Androgen Antagonists 20Methods 19Therapeutics 18Radiotherapy, Intensity-Modulated 18Interviews as Topic 18Cystectomy 16Educational Status 15Biopsy 15Psychiatric Rehabilitation 14Practice Guidelines as Topic 14Diet Therapy 14Sunitinib 12Specimen Handling 12Resistance Training 12gallium 68 PSMA-11 11Radiation 11Watchful Waiting 9Surgical Procedures, Operative 9Proton Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × luprolide acetate gel depot × Genitourinary × Clear all
NCT04239599 2022-09-29

RCT-PHART2

Sunnybrook Health Sciences Centre

Phase NA Unknown
178 enrolled
Genitourinary

Prostatic Neoplasms

NCT01344564 2013-03-18

Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide

Urology of Virginia

Phase NA Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡